GlycoMimetics, Inc. :: An Introduction

GlycoMimetics, Inc. is developing novel small molecule drugs
to treat orphan diseases.

Information Request Form

Thank you for visiting our website and for your commitment to advocating on behalf of individuals with sickle cell disease. As we continue furthering our knowledge of sickle cell disease through the study of GMI-1070, a novel investigational drug for vaso-occlusive crisis (VOC), we welcome the opportunity to keep organizations and individuals abreast of our progress, as well as to share ways that you can join us in our efforts. If you would like to receive program materials for you and/or your members, please fill out the form below. Your information will only be used to contact you regarding the trial.

Organization Name:
* Your Name:
Address:
	City: State: Zip:
* E-mail address:
Phone Number:
* How Did You Hear About the Trial?	PSA Radio Spot Newspaper Website Trial Site (which site)? Other
Type of Information You Would Like:	Information about trial sites in your area. A representative to contact you with information about the trial for your organization's membership.
	Thank you and if you have any questions, please contact Shanti Rodriguez at 240-243-1227.